Journal article 1119 views 137 downloads
Efficacy and safety of linagliptin in type 2 diabetes patients with self-reported hepatic disorders: A retrospective pooled analysis of 17 randomized, double-blind, placebo-controlled clinical trials
Nobuya Inagaki,
Wayne H.-H. Sheu,
David Owens ,
Susanne Crowe,
Amit Bhandari,
Yan Gong,
Sanjay Patel
Journal of Diabetes and its Complications, Volume: 30, Issue: 8, Pages: 1622 - 1630
Swansea University Author: David Owens
-
PDF | Accepted Manuscript
Download (1.04MB)
DOI (Published version): 10.1016/j.jdiacomp.2016.07.002
Abstract
Efficacy and safety of linagliptin in type 2 diabetes patients with self-reported hepatic disorders: A retrospective pooled analysis of 17 randomized, double-blind, placebo-controlled clinical trials
Published in: | Journal of Diabetes and its Complications |
---|---|
ISSN: | 10568727 |
Published: |
2016
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa29221 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
first_indexed |
2016-07-15T18:57:49Z |
---|---|
last_indexed |
2018-02-09T05:14:10Z |
id |
cronfa29221 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2017-01-19T10:10:31.5004113</datestamp><bib-version>v2</bib-version><id>29221</id><entry>2016-07-15</entry><title>Efficacy and safety of linagliptin in type 2 diabetes patients with self-reported hepatic disorders: A retrospective pooled analysis of 17 randomized, double-blind, placebo-controlled clinical trials</title><swanseaauthors><author><sid>2fd4b7c3f82c6d3bd546eff61ff944e9</sid><ORCID>0000-0003-1002-1238</ORCID><firstname>David</firstname><surname>Owens</surname><name>David Owens</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2016-07-15</date><deptcode>BMS</deptcode><abstract/><type>Journal Article</type><journal>Journal of Diabetes and its Complications</journal><volume>30</volume><journalNumber>8</journalNumber><paginationStart>1622</paginationStart><paginationEnd>1630</paginationEnd><publisher/><issnPrint>10568727</issnPrint><keywords/><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2016</publishedYear><publishedDate>2016-12-31</publishedDate><doi>10.1016/j.jdiacomp.2016.07.002</doi><url/><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2017-01-19T10:10:31.5004113</lastEdited><Created>2016-07-15T14:34:52.5548657</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Nobuya</firstname><surname>Inagaki</surname><order>1</order></author><author><firstname>Wayne H.-H.</firstname><surname>Sheu</surname><order>2</order></author><author><firstname>David</firstname><surname>Owens</surname><orcid>0000-0003-1002-1238</orcid><order>3</order></author><author><firstname>Susanne</firstname><surname>Crowe</surname><order>4</order></author><author><firstname>Amit</firstname><surname>Bhandari</surname><order>5</order></author><author><firstname>Yan</firstname><surname>Gong</surname><order>6</order></author><author><firstname>Sanjay</firstname><surname>Patel</surname><order>7</order></author></authors><documents><document><filename>0029221-15072016144023.pdf</filename><originalFilename>Inagakietal.pdf</originalFilename><uploaded>2016-07-15T14:40:23.2170000</uploaded><type>Output</type><contentLength>1220224</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><embargoDate>2017-07-14T00:00:00.0000000</embargoDate><copyrightCorrect>true</copyrightCorrect></document></documents><OutputDurs/></rfc1807> |
spelling |
2017-01-19T10:10:31.5004113 v2 29221 2016-07-15 Efficacy and safety of linagliptin in type 2 diabetes patients with self-reported hepatic disorders: A retrospective pooled analysis of 17 randomized, double-blind, placebo-controlled clinical trials 2fd4b7c3f82c6d3bd546eff61ff944e9 0000-0003-1002-1238 David Owens David Owens true false 2016-07-15 BMS Journal Article Journal of Diabetes and its Complications 30 8 1622 1630 10568727 31 12 2016 2016-12-31 10.1016/j.jdiacomp.2016.07.002 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University 2017-01-19T10:10:31.5004113 2016-07-15T14:34:52.5548657 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Nobuya Inagaki 1 Wayne H.-H. Sheu 2 David Owens 0000-0003-1002-1238 3 Susanne Crowe 4 Amit Bhandari 5 Yan Gong 6 Sanjay Patel 7 0029221-15072016144023.pdf Inagakietal.pdf 2016-07-15T14:40:23.2170000 Output 1220224 application/pdf Accepted Manuscript true 2017-07-14T00:00:00.0000000 true |
title |
Efficacy and safety of linagliptin in type 2 diabetes patients with self-reported hepatic disorders: A retrospective pooled analysis of 17 randomized, double-blind, placebo-controlled clinical trials |
spellingShingle |
Efficacy and safety of linagliptin in type 2 diabetes patients with self-reported hepatic disorders: A retrospective pooled analysis of 17 randomized, double-blind, placebo-controlled clinical trials David Owens |
title_short |
Efficacy and safety of linagliptin in type 2 diabetes patients with self-reported hepatic disorders: A retrospective pooled analysis of 17 randomized, double-blind, placebo-controlled clinical trials |
title_full |
Efficacy and safety of linagliptin in type 2 diabetes patients with self-reported hepatic disorders: A retrospective pooled analysis of 17 randomized, double-blind, placebo-controlled clinical trials |
title_fullStr |
Efficacy and safety of linagliptin in type 2 diabetes patients with self-reported hepatic disorders: A retrospective pooled analysis of 17 randomized, double-blind, placebo-controlled clinical trials |
title_full_unstemmed |
Efficacy and safety of linagliptin in type 2 diabetes patients with self-reported hepatic disorders: A retrospective pooled analysis of 17 randomized, double-blind, placebo-controlled clinical trials |
title_sort |
Efficacy and safety of linagliptin in type 2 diabetes patients with self-reported hepatic disorders: A retrospective pooled analysis of 17 randomized, double-blind, placebo-controlled clinical trials |
author_id_str_mv |
2fd4b7c3f82c6d3bd546eff61ff944e9 |
author_id_fullname_str_mv |
2fd4b7c3f82c6d3bd546eff61ff944e9_***_David Owens |
author |
David Owens |
author2 |
Nobuya Inagaki Wayne H.-H. Sheu David Owens Susanne Crowe Amit Bhandari Yan Gong Sanjay Patel |
format |
Journal article |
container_title |
Journal of Diabetes and its Complications |
container_volume |
30 |
container_issue |
8 |
container_start_page |
1622 |
publishDate |
2016 |
institution |
Swansea University |
issn |
10568727 |
doi_str_mv |
10.1016/j.jdiacomp.2016.07.002 |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
document_store_str |
1 |
active_str |
0 |
published_date |
2016-12-31T03:35:36Z |
_version_ |
1763751532278317056 |
score |
11.036706 |